Medications for Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome).
Found 1 Approved Drug for Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome)
Mepsevii
Generic Name
Vestronidase
Mepsevii
Generic Name
Vestronidase
Form: Injection
Method of administration: Intravenous
FDA approval date: November 15, 2017
Classification: Lysosomal beta Glucuronidase
MEPSEVII is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome). Limitations of Use The effect of MEPSEVII on the central nervous system manifestations of MPS VII has not been determined. MEPSEVII is a recombinant human lysosomal beta glucuronidase indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome). Limitations of Use The effect of MEPSEVII on the central nervous system manifestations of MPS VII has not been determined. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances